This week on dvm360: Research finds oral microbiome in canines can lead to early detection of periodontal disease, and other news

Good afternoon dvm360 readers and happy Monday! We cannot believe that we are now entering the final month of summer. As students prepare to head back to veterinary school, dvm360 will soon be announcing the opening of our Student Ambassador Program. Students within any class in veterinary school are welcome to apply for a chance to be entered in the program. Stay tuned for more information!

Here is what readers can find this week on dvm360.com:

• Anivive Lifesciences Inc, a One Health technology company, shared the news that the National Institute of Allergy and Infectious Diseases, part of the National Institute of Health, awarded the company a new contract worth millions to support the creation of a vaccine against the cause of Valley Fever, fungus Coccidioides
• During an interview with dvm360 previewing his upcoming Fetch Kansas City lecture, Craig A Clifford DVM, MS, DACVIM (Oncology), shares more on how general practitioners can utilize phenotyping when it comes to canine lymphoma patients before they are referred to their local veterinary oncologist.
• On this week's episode of The Vet Blast Podcast, our host Adam Christman, DVM, MBA, welcomed back David Dycus, DVM, MS, CCRP, to take listeners into the world of orthopedics.
• The New York State Veterinary Diagnostic Laboratory (NYSVDL) at Cornell University has received $19.5 million in capital funding from lawmakers to expand the building as a way to better accommodate the laboratory’s increasing case load.
• A study recently published by Frontiers in Veterinary Science conducted by the Waltham Petcare Science Institute show researchers that the oral microbiome offers crucial information that could be key for early detection of periodontal diseases.